nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—PTGS2—colon cancer	0.32	1	CbGaD
Flurbiprofen—UGT1A9—Irinotecan—colon cancer	0.108	0.224	CbGbCtD
Flurbiprofen—UGT1A1—Irinotecan—colon cancer	0.0883	0.183	CbGbCtD
Flurbiprofen—ABCC4—Fluorouracil—colon cancer	0.0867	0.18	CbGbCtD
Flurbiprofen—ABCC4—Methotrexate—colon cancer	0.0478	0.0993	CbGbCtD
Flurbiprofen—ALB—Irinotecan—colon cancer	0.0335	0.0695	CbGbCtD
Flurbiprofen—ALB—Fluorouracil—colon cancer	0.0321	0.0667	CbGbCtD
Flurbiprofen—CYP2C9—Capecitabine—colon cancer	0.0292	0.0607	CbGbCtD
Flurbiprofen—SLC22A6—Methotrexate—colon cancer	0.0208	0.0432	CbGbCtD
Flurbiprofen—ALB—Methotrexate—colon cancer	0.0177	0.0368	CbGbCtD
Flurbiprofen—CYP2C9—Fluorouracil—colon cancer	0.0173	0.036	CbGbCtD
Flurbiprofen—UGT1A3—digestive system—colon cancer	0.00198	0.061	CbGeAlD
Flurbiprofen—UGT1A9—renal system—colon cancer	0.00172	0.053	CbGeAlD
Flurbiprofen—ALB—gall bladder—colon cancer	0.00165	0.0509	CbGeAlD
Flurbiprofen—UGT2B4—liver—colon cancer	0.00153	0.0474	CbGeAlD
Flurbiprofen—UGT1A3—liver—colon cancer	0.00147	0.0454	CbGeAlD
Flurbiprofen—UGT1A9—digestive system—colon cancer	0.00141	0.0434	CbGeAlD
Flurbiprofen—UGT2B7—renal system—colon cancer	0.00138	0.0427	CbGeAlD
Flurbiprofen—UGT1A1—renal system—colon cancer	0.00118	0.0363	CbGeAlD
Flurbiprofen—UGT2B7—digestive system—colon cancer	0.00113	0.035	CbGeAlD
Flurbiprofen—PTGS1—endothelium—colon cancer	0.00108	0.0334	CbGeAlD
Flurbiprofen—UGT1A9—liver—colon cancer	0.00105	0.0324	CbGeAlD
Flurbiprofen—PTGS2—endothelium—colon cancer	0.00104	0.032	CbGeAlD
Flurbiprofen—PTGS1—blood vessel—colon cancer	0.000999	0.0308	CbGeAlD
Flurbiprofen—UGT1A1—digestive system—colon cancer	0.000965	0.0298	CbGeAlD
Flurbiprofen—PTGS2—blood vessel—colon cancer	0.000955	0.0295	CbGeAlD
Flurbiprofen—PTGS2—gall bladder—colon cancer	0.000899	0.0277	CbGeAlD
Flurbiprofen—UGT2B7—liver—colon cancer	0.000845	0.0261	CbGeAlD
Flurbiprofen—ABCC4—renal system—colon cancer	0.000766	0.0237	CbGeAlD
Flurbiprofen—UGT1A1—liver—colon cancer	0.000719	0.0222	CbGeAlD
Flurbiprofen—ABCC4—digestive system—colon cancer	0.000629	0.0194	CbGeAlD
Flurbiprofen—ABCC4—bone marrow—colon cancer	0.000579	0.0179	CbGeAlD
Flurbiprofen—PTGS2—embryo—colon cancer	0.00057	0.0176	CbGeAlD
Flurbiprofen—Carprofen—PTGS2—colon cancer	0.0005	0.115	CrCbGaD
Flurbiprofen—PTGS1—epithelium—colon cancer	0.000486	0.015	CbGeAlD
Flurbiprofen—ALB—liver—colon cancer	0.000484	0.0149	CbGeAlD
Flurbiprofen—PTGS1—smooth muscle tissue—colon cancer	0.000469	0.0145	CbGeAlD
Flurbiprofen—ABCC4—liver—colon cancer	0.000468	0.0145	CbGeAlD
Flurbiprofen—PTGS2—epithelium—colon cancer	0.000465	0.0143	CbGeAlD
Flurbiprofen—PTGS1—renal system—colon cancer	0.000451	0.0139	CbGeAlD
Flurbiprofen—PTGS2—smooth muscle tissue—colon cancer	0.000448	0.0138	CbGeAlD
Flurbiprofen—PTGS2—renal system—colon cancer	0.000431	0.0133	CbGeAlD
Flurbiprofen—Tiaprofenic acid—PTGS2—colon cancer	0.000408	0.0937	CrCbGaD
Flurbiprofen—CYP2C9—digestive system—colon cancer	0.000405	0.0125	CbGeAlD
Flurbiprofen—ALB—lymph node—colon cancer	0.000371	0.0114	CbGeAlD
Flurbiprofen—Fenbufen—PTGS2—colon cancer	0.000371	0.0853	CrCbGaD
Flurbiprofen—PTGS1—digestive system—colon cancer	0.00037	0.0114	CbGeAlD
Flurbiprofen—Ibuprofen—PPARG—colon cancer	0.000367	0.0843	CrCbGaD
Flurbiprofen—ABCC4—lymph node—colon cancer	0.000359	0.0111	CbGeAlD
Flurbiprofen—PTGS2—lymphoid tissue—colon cancer	0.000358	0.0111	CbGeAlD
Flurbiprofen—Diflunisal—PTGS2—colon cancer	0.000356	0.0819	CrCbGaD
Flurbiprofen—PTGS2—digestive system—colon cancer	0.000354	0.0109	CbGeAlD
Flurbiprofen—PTGS1—vagina—colon cancer	0.000327	0.0101	CbGeAlD
Flurbiprofen—PTGS2—bone marrow—colon cancer	0.000326	0.0101	CbGeAlD
Flurbiprofen—Oxaprozin—PTGS2—colon cancer	0.000322	0.0741	CrCbGaD
Flurbiprofen—Salsalate—PTGS2—colon cancer	0.000322	0.0741	CrCbGaD
Flurbiprofen—PTGS2—vagina—colon cancer	0.000312	0.00964	CbGeAlD
Flurbiprofen—Suprofen—PTGS2—colon cancer	0.000309	0.071	CrCbGaD
Flurbiprofen—CYP2C9—liver—colon cancer	0.000302	0.00932	CbGeAlD
Flurbiprofen—Fenoprofen—PTGS2—colon cancer	0.000266	0.0612	CrCbGaD
Flurbiprofen—PTGS2—liver—colon cancer	0.000264	0.00813	CbGeAlD
Flurbiprofen—Mefenamic acid—PTGS2—colon cancer	0.000247	0.0568	CrCbGaD
Flurbiprofen—Naproxen—PTGS2—colon cancer	0.000242	0.0558	CrCbGaD
Flurbiprofen—Pancytopenia—Capecitabine—colon cancer	0.000224	0.00165	CcSEcCtD
Flurbiprofen—Malaise—Irinotecan—colon cancer	0.000222	0.00163	CcSEcCtD
Flurbiprofen—Vertigo—Irinotecan—colon cancer	0.000221	0.00162	CcSEcCtD
Flurbiprofen—Dysuria—Capecitabine—colon cancer	0.000221	0.00162	CcSEcCtD
Flurbiprofen—Neutropenia—Capecitabine—colon cancer	0.000221	0.00162	CcSEcCtD
Flurbiprofen—Syncope—Irinotecan—colon cancer	0.00022	0.00162	CcSEcCtD
Flurbiprofen—Leukopenia—Irinotecan—colon cancer	0.00022	0.00162	CcSEcCtD
Flurbiprofen—Convulsion—Vincristine—colon cancer	0.000219	0.00161	CcSEcCtD
Flurbiprofen—Hypertension—Vincristine—colon cancer	0.000218	0.0016	CcSEcCtD
Flurbiprofen—Anaemia—Fluorouracil—colon cancer	0.000218	0.0016	CcSEcCtD
Flurbiprofen—Loss of consciousness—Irinotecan—colon cancer	0.000216	0.00159	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Methotrexate—colon cancer	0.000216	0.00158	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Capecitabine—colon cancer	0.000216	0.00158	CcSEcCtD
Flurbiprofen—Myalgia—Vincristine—colon cancer	0.000215	0.00158	CcSEcCtD
Flurbiprofen—Cough—Irinotecan—colon cancer	0.000215	0.00158	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Capecitabine—colon cancer	0.000213	0.00156	CcSEcCtD
Flurbiprofen—Hypertension—Irinotecan—colon cancer	0.000212	0.00156	CcSEcCtD
Flurbiprofen—Pneumonia—Capecitabine—colon cancer	0.000212	0.00156	CcSEcCtD
Flurbiprofen—PTGS1—lymph node—colon cancer	0.000211	0.00652	CbGeAlD
Flurbiprofen—Leukopenia—Fluorouracil—colon cancer	0.000211	0.00155	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000209	0.00153	CcSEcCtD
Flurbiprofen—Acute coronary syndrome—Capecitabine—colon cancer	0.000208	0.00152	CcSEcCtD
Flurbiprofen—Cerebrovascular accident—Methotrexate—colon cancer	0.000208	0.00152	CcSEcCtD
Flurbiprofen—Renal failure—Capecitabine—colon cancer	0.000207	0.00152	CcSEcCtD
Flurbiprofen—Discomfort—Irinotecan—colon cancer	0.000207	0.00152	CcSEcCtD
Flurbiprofen—Myocardial infarction—Capecitabine—colon cancer	0.000206	0.00152	CcSEcCtD
Flurbiprofen—Oedema—Vincristine—colon cancer	0.000206	0.00151	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Vincristine—colon cancer	0.000206	0.00151	CcSEcCtD
Flurbiprofen—Jaundice—Capecitabine—colon cancer	0.000205	0.00151	CcSEcCtD
Flurbiprofen—Stomatitis—Capecitabine—colon cancer	0.000205	0.00151	CcSEcCtD
Flurbiprofen—Infection—Vincristine—colon cancer	0.000205	0.0015	CcSEcCtD
Flurbiprofen—Conjunctivitis—Capecitabine—colon cancer	0.000205	0.0015	CcSEcCtD
Flurbiprofen—Urinary tract infection—Capecitabine—colon cancer	0.000205	0.0015	CcSEcCtD
Flurbiprofen—Convulsion—Fluorouracil—colon cancer	0.000204	0.0015	CcSEcCtD
Flurbiprofen—Osteoarthritis—Methotrexate—colon cancer	0.000203	0.00149	CcSEcCtD
Flurbiprofen—Confusional state—Irinotecan—colon cancer	0.000202	0.00149	CcSEcCtD
Flurbiprofen—PTGS2—lymph node—colon cancer	0.000202	0.00624	CbGeAlD
Flurbiprofen—Thrombocytopenia—Vincristine—colon cancer	0.000202	0.00148	CcSEcCtD
Flurbiprofen—Haematuria—Capecitabine—colon cancer	0.000201	0.00147	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Irinotecan—colon cancer	0.000201	0.00147	CcSEcCtD
Flurbiprofen—Oedema—Irinotecan—colon cancer	0.000201	0.00147	CcSEcCtD
Flurbiprofen—Myalgia—Fluorouracil—colon cancer	0.0002	0.00147	CcSEcCtD
Flurbiprofen—Infection—Irinotecan—colon cancer	0.000199	0.00146	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Vincristine—colon cancer	0.000199	0.00146	CcSEcCtD
Flurbiprofen—Epistaxis—Capecitabine—colon cancer	0.000199	0.00146	CcSEcCtD
Flurbiprofen—Discomfort—Fluorouracil—colon cancer	0.000198	0.00145	CcSEcCtD
Flurbiprofen—Shock—Irinotecan—colon cancer	0.000197	0.00145	CcSEcCtD
Flurbiprofen—Agranulocytosis—Capecitabine—colon cancer	0.000197	0.00144	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Irinotecan—colon cancer	0.000196	0.00144	CcSEcCtD
Flurbiprofen—Anorexia—Vincristine—colon cancer	0.000196	0.00144	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Irinotecan—colon cancer	0.000194	0.00142	CcSEcCtD
Flurbiprofen—Confusional state—Fluorouracil—colon cancer	0.000194	0.00142	CcSEcCtD
Flurbiprofen—Mood swings—Methotrexate—colon cancer	0.000193	0.00141	CcSEcCtD
Flurbiprofen—Hypotension—Vincristine—colon cancer	0.000193	0.00141	CcSEcCtD
Flurbiprofen—Oedema—Fluorouracil—colon cancer	0.000192	0.00141	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Fluorouracil—colon cancer	0.000192	0.00141	CcSEcCtD
Flurbiprofen—Anorexia—Irinotecan—colon cancer	0.000191	0.0014	CcSEcCtD
Flurbiprofen—Ataxia—Methotrexate—colon cancer	0.000191	0.0014	CcSEcCtD
Flurbiprofen—Infection—Fluorouracil—colon cancer	0.000191	0.0014	CcSEcCtD
Flurbiprofen—Haemoglobin—Capecitabine—colon cancer	0.00019	0.00139	CcSEcCtD
Flurbiprofen—Rhinitis—Capecitabine—colon cancer	0.00019	0.00139	CcSEcCtD
Flurbiprofen—Haemorrhage—Capecitabine—colon cancer	0.000189	0.00139	CcSEcCtD
Flurbiprofen—Hepatitis—Capecitabine—colon cancer	0.000189	0.00139	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Fluorouracil—colon cancer	0.000188	0.00138	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Vincristine—colon cancer	0.000188	0.00138	CcSEcCtD
Flurbiprofen—Pharyngitis—Capecitabine—colon cancer	0.000188	0.00138	CcSEcCtD
Flurbiprofen—Tachycardia—Fluorouracil—colon cancer	0.000188	0.00138	CcSEcCtD
Flurbiprofen—Hypotension—Irinotecan—colon cancer	0.000188	0.00138	CcSEcCtD
Flurbiprofen—Insomnia—Vincristine—colon cancer	0.000186	0.00137	CcSEcCtD
Flurbiprofen—Paraesthesia—Vincristine—colon cancer	0.000185	0.00136	CcSEcCtD
Flurbiprofen—Anorexia—Fluorouracil—colon cancer	0.000183	0.00135	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000183	0.00134	CcSEcCtD
Flurbiprofen—Visual impairment—Capecitabine—colon cancer	0.000182	0.00134	CcSEcCtD
Flurbiprofen—Insomnia—Irinotecan—colon cancer	0.000181	0.00133	CcSEcCtD
Flurbiprofen—Paraesthesia—Irinotecan—colon cancer	0.00018	0.00132	CcSEcCtD
Flurbiprofen—Hypotension—Fluorouracil—colon cancer	0.00018	0.00132	CcSEcCtD
Flurbiprofen—Decreased appetite—Vincristine—colon cancer	0.000179	0.00132	CcSEcCtD
Flurbiprofen—Dyspnoea—Irinotecan—colon cancer	0.000179	0.00131	CcSEcCtD
Flurbiprofen—Erythema multiforme—Capecitabine—colon cancer	0.000179	0.00131	CcSEcCtD
Flurbiprofen—Somnolence—Irinotecan—colon cancer	0.000178	0.00131	CcSEcCtD
Flurbiprofen—Dyspepsia—Irinotecan—colon cancer	0.000177	0.0013	CcSEcCtD
Flurbiprofen—Tinnitus—Capecitabine—colon cancer	0.000176	0.00129	CcSEcCtD
Flurbiprofen—Pain—Vincristine—colon cancer	0.000176	0.00129	CcSEcCtD
Flurbiprofen—Constipation—Vincristine—colon cancer	0.000176	0.00129	CcSEcCtD
Flurbiprofen—Asthma—Methotrexate—colon cancer	0.000176	0.00129	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000175	0.00129	CcSEcCtD
Flurbiprofen—Decreased appetite—Irinotecan—colon cancer	0.000174	0.00128	CcSEcCtD
Flurbiprofen—Eosinophilia—Methotrexate—colon cancer	0.000174	0.00128	CcSEcCtD
Flurbiprofen—Insomnia—Fluorouracil—colon cancer	0.000174	0.00128	CcSEcCtD
Flurbiprofen—Paraesthesia—Fluorouracil—colon cancer	0.000173	0.00127	CcSEcCtD
Flurbiprofen—Pancreatitis—Methotrexate—colon cancer	0.000172	0.00127	CcSEcCtD
Flurbiprofen—Pain—Irinotecan—colon cancer	0.000172	0.00126	CcSEcCtD
Flurbiprofen—Constipation—Irinotecan—colon cancer	0.000172	0.00126	CcSEcCtD
Flurbiprofen—Angiopathy—Capecitabine—colon cancer	0.000172	0.00126	CcSEcCtD
Flurbiprofen—Dyspnoea—Fluorouracil—colon cancer	0.000171	0.00126	CcSEcCtD
Flurbiprofen—Somnolence—Fluorouracil—colon cancer	0.000171	0.00125	CcSEcCtD
Flurbiprofen—Chills—Capecitabine—colon cancer	0.00017	0.00125	CcSEcCtD
Flurbiprofen—Dyspepsia—Fluorouracil—colon cancer	0.000169	0.00124	CcSEcCtD
Flurbiprofen—Arrhythmia—Capecitabine—colon cancer	0.000169	0.00124	CcSEcCtD
Flurbiprofen—Abdominal discomfort—Methotrexate—colon cancer	0.000169	0.00124	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Vincristine—colon cancer	0.000168	0.00124	CcSEcCtD
Flurbiprofen—Decreased appetite—Fluorouracil—colon cancer	0.000167	0.00123	CcSEcCtD
Flurbiprofen—Alopecia—Capecitabine—colon cancer	0.000167	0.00123	CcSEcCtD
Flurbiprofen—Pancytopenia—Methotrexate—colon cancer	0.000167	0.00123	CcSEcCtD
Flurbiprofen—Feeling abnormal—Irinotecan—colon cancer	0.000165	0.00121	CcSEcCtD
Flurbiprofen—Neutropenia—Methotrexate—colon cancer	0.000164	0.00121	CcSEcCtD
Flurbiprofen—Dysuria—Methotrexate—colon cancer	0.000164	0.00121	CcSEcCtD
Flurbiprofen—Pain—Fluorouracil—colon cancer	0.000164	0.00121	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Irinotecan—colon cancer	0.000164	0.0012	CcSEcCtD
Flurbiprofen—Body temperature increased—Vincristine—colon cancer	0.000163	0.0012	CcSEcCtD
Flurbiprofen—Abdominal pain—Vincristine—colon cancer	0.000163	0.0012	CcSEcCtD
Flurbiprofen—Flatulence—Capecitabine—colon cancer	0.000162	0.00119	CcSEcCtD
Flurbiprofen—Erectile dysfunction—Methotrexate—colon cancer	0.000162	0.00119	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Methotrexate—colon cancer	0.00016	0.00118	CcSEcCtD
Flurbiprofen—Abdominal pain—Irinotecan—colon cancer	0.000159	0.00116	CcSEcCtD
Flurbiprofen—Body temperature increased—Irinotecan—colon cancer	0.000159	0.00116	CcSEcCtD
Flurbiprofen—Feeling abnormal—Fluorouracil—colon cancer	0.000158	0.00116	CcSEcCtD
Flurbiprofen—Pneumonia—Methotrexate—colon cancer	0.000158	0.00116	CcSEcCtD
Flurbiprofen—Ketoprofen—PTGS2—colon cancer	0.000157	0.0361	CrCbGaD
Flurbiprofen—Drowsiness—Methotrexate—colon cancer	0.000157	0.00115	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000155	0.00114	CcSEcCtD
Flurbiprofen—Ibuprofen—PTGS2—colon cancer	0.000155	0.0356	CrCbGaD
Flurbiprofen—Tremor—Capecitabine—colon cancer	0.000154	0.00113	CcSEcCtD
Flurbiprofen—Renal failure—Methotrexate—colon cancer	0.000154	0.00113	CcSEcCtD
Flurbiprofen—Stomatitis—Methotrexate—colon cancer	0.000153	0.00112	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Capecitabine—colon cancer	0.000153	0.00112	CcSEcCtD
Flurbiprofen—Urticaria—Fluorouracil—colon cancer	0.000153	0.00112	CcSEcCtD
Flurbiprofen—Conjunctivitis—Methotrexate—colon cancer	0.000152	0.00112	CcSEcCtD
Flurbiprofen—Anaemia—Capecitabine—colon cancer	0.000152	0.00112	CcSEcCtD
Flurbiprofen—Body temperature increased—Fluorouracil—colon cancer	0.000152	0.00112	CcSEcCtD
Flurbiprofen—Hypersensitivity—Vincristine—colon cancer	0.000152	0.00111	CcSEcCtD
Flurbiprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	0.000151	0.00598	CbGpPWpGaD
Flurbiprofen—UGT1A9—PPAR Alpha Pathway—MYC—colon cancer	0.00015	0.00596	CbGpPWpGaD
Flurbiprofen—Sweating—Methotrexate—colon cancer	0.00015	0.0011	CcSEcCtD
Flurbiprofen—Haematuria—Methotrexate—colon cancer	0.000149	0.0011	CcSEcCtD
Flurbiprofen—Malaise—Capecitabine—colon cancer	0.000148	0.00109	CcSEcCtD
Flurbiprofen—Epistaxis—Methotrexate—colon cancer	0.000148	0.00109	CcSEcCtD
Flurbiprofen—Vertigo—Capecitabine—colon cancer	0.000148	0.00109	CcSEcCtD
Flurbiprofen—Hypersensitivity—Irinotecan—colon cancer	0.000148	0.00109	CcSEcCtD
Flurbiprofen—Asthenia—Vincristine—colon cancer	0.000148	0.00109	CcSEcCtD
Flurbiprofen—Syncope—Capecitabine—colon cancer	0.000148	0.00108	CcSEcCtD
Flurbiprofen—Leukopenia—Capecitabine—colon cancer	0.000147	0.00108	CcSEcCtD
Flurbiprofen—Agranulocytosis—Methotrexate—colon cancer	0.000146	0.00107	CcSEcCtD
Flurbiprofen—UGT2B4—Metabolism—ODC1—colon cancer	0.000146	0.0058	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—CHST5—colon cancer	0.000146	0.0058	CbGpPWpGaD
Flurbiprofen—Palpitations—Capecitabine—colon cancer	0.000145	0.00107	CcSEcCtD
Flurbiprofen—Loss of consciousness—Capecitabine—colon cancer	0.000145	0.00106	CcSEcCtD
Flurbiprofen—Asthenia—Irinotecan—colon cancer	0.000144	0.00106	CcSEcCtD
Flurbiprofen—Cough—Capecitabine—colon cancer	0.000144	0.00105	CcSEcCtD
Flurbiprofen—Hypertension—Capecitabine—colon cancer	0.000142	0.00104	CcSEcCtD
Flurbiprofen—Hypersensitivity—Fluorouracil—colon cancer	0.000142	0.00104	CcSEcCtD
Flurbiprofen—Haemoglobin—Methotrexate—colon cancer	0.000141	0.00104	CcSEcCtD
Flurbiprofen—Diarrhoea—Vincristine—colon cancer	0.000141	0.00104	CcSEcCtD
Flurbiprofen—Hepatitis—Methotrexate—colon cancer	0.000141	0.00103	CcSEcCtD
Flurbiprofen—Haemorrhage—Methotrexate—colon cancer	0.000141	0.00103	CcSEcCtD
Flurbiprofen—Myalgia—Capecitabine—colon cancer	0.00014	0.00103	CcSEcCtD
Flurbiprofen—Pharyngitis—Methotrexate—colon cancer	0.00014	0.00103	CcSEcCtD
Flurbiprofen—Anxiety—Capecitabine—colon cancer	0.00014	0.00103	CcSEcCtD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000139	0.0055	CbGpPWpGaD
Flurbiprofen—Discomfort—Capecitabine—colon cancer	0.000138	0.00102	CcSEcCtD
Flurbiprofen—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000138	0.00545	CbGpPWpGaD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000138	0.00545	CbGpPWpGaD
Flurbiprofen—Diarrhoea—Irinotecan—colon cancer	0.000137	0.00101	CcSEcCtD
Flurbiprofen—Dry mouth—Capecitabine—colon cancer	0.000137	0.00101	CcSEcCtD
Flurbiprofen—Dizziness—Vincristine—colon cancer	0.000136	0.001	CcSEcCtD
Flurbiprofen—Pruritus—Fluorouracil—colon cancer	0.000136	0.000998	CcSEcCtD
Flurbiprofen—PTGS2—S1P1 pathway—VEGFA—colon cancer	0.000136	0.00539	CbGpPWpGaD
Flurbiprofen—Visual impairment—Methotrexate—colon cancer	0.000136	0.000996	CcSEcCtD
Flurbiprofen—Confusional state—Capecitabine—colon cancer	0.000135	0.000994	CcSEcCtD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000135	0.00535	CbGpPWpGaD
Flurbiprofen—Oedema—Capecitabine—colon cancer	0.000134	0.000986	CcSEcCtD
Flurbiprofen—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	0.000134	0.0053	CbGpPWpGaD
Flurbiprofen—Infection—Capecitabine—colon cancer	0.000133	0.00098	CcSEcCtD
Flurbiprofen—Erythema multiforme—Methotrexate—colon cancer	0.000133	0.000977	CcSEcCtD
Flurbiprofen—Dizziness—Irinotecan—colon cancer	0.000133	0.000974	CcSEcCtD
Flurbiprofen—Shock—Capecitabine—colon cancer	0.000132	0.00097	CcSEcCtD
Flurbiprofen—Ibuprofen—ABCB1—colon cancer	0.000132	0.0303	CrCbGaD
Flurbiprofen—Diarrhoea—Fluorouracil—colon cancer	0.000131	0.000965	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Capecitabine—colon cancer	0.000131	0.000965	CcSEcCtD
Flurbiprofen—Tinnitus—Methotrexate—colon cancer	0.000131	0.000963	CcSEcCtD
Flurbiprofen—Tachycardia—Capecitabine—colon cancer	0.000131	0.000962	CcSEcCtD
Flurbiprofen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000131	0.0052	CbGpPWpGaD
Flurbiprofen—Vomiting—Vincristine—colon cancer	0.000131	0.000962	CcSEcCtD
Flurbiprofen—Rash—Vincristine—colon cancer	0.00013	0.000954	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Capecitabine—colon cancer	0.00013	0.000953	CcSEcCtD
Flurbiprofen—Dermatitis—Vincristine—colon cancer	0.00013	0.000953	CcSEcCtD
Flurbiprofen—UGT1A3—Metabolism—CA7—colon cancer	0.000129	0.00512	CbGpPWpGaD
Flurbiprofen—Headache—Vincristine—colon cancer	0.000129	0.000948	CcSEcCtD
Flurbiprofen—Anorexia—Capecitabine—colon cancer	0.000128	0.00094	CcSEcCtD
Flurbiprofen—Angiopathy—Methotrexate—colon cancer	0.000128	0.000937	CcSEcCtD
Flurbiprofen—Vomiting—Irinotecan—colon cancer	0.000128	0.000937	CcSEcCtD
Flurbiprofen—Dizziness—Fluorouracil—colon cancer	0.000127	0.000933	CcSEcCtD
Flurbiprofen—Rash—Irinotecan—colon cancer	0.000127	0.000929	CcSEcCtD
Flurbiprofen—Dermatitis—Irinotecan—colon cancer	0.000126	0.000928	CcSEcCtD
Flurbiprofen—Chills—Methotrexate—colon cancer	0.000126	0.000927	CcSEcCtD
Flurbiprofen—Headache—Irinotecan—colon cancer	0.000126	0.000923	CcSEcCtD
Flurbiprofen—Hypotension—Capecitabine—colon cancer	0.000125	0.000921	CcSEcCtD
Flurbiprofen—Alopecia—Methotrexate—colon cancer	0.000124	0.000913	CcSEcCtD
Flurbiprofen—Nausea—Vincristine—colon cancer	0.000122	0.000899	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000122	0.000898	CcSEcCtD
Flurbiprofen—Vomiting—Fluorouracil—colon cancer	0.000122	0.000897	CcSEcCtD
Flurbiprofen—Insomnia—Capecitabine—colon cancer	0.000121	0.000892	CcSEcCtD
Flurbiprofen—Rash—Fluorouracil—colon cancer	0.000121	0.00089	CcSEcCtD
Flurbiprofen—Dermatitis—Fluorouracil—colon cancer	0.000121	0.000889	CcSEcCtD
Flurbiprofen—Paraesthesia—Capecitabine—colon cancer	0.000121	0.000885	CcSEcCtD
Flurbiprofen—Headache—Fluorouracil—colon cancer	0.00012	0.000884	CcSEcCtD
Flurbiprofen—Dyspnoea—Capecitabine—colon cancer	0.00012	0.000879	CcSEcCtD
Flurbiprofen—Nausea—Irinotecan—colon cancer	0.000119	0.000875	CcSEcCtD
Flurbiprofen—Dyspepsia—Capecitabine—colon cancer	0.000118	0.000868	CcSEcCtD
Flurbiprofen—ABCC4—Fluoropyrimidine Activity—TP53—colon cancer	0.000118	0.00468	CbGpPWpGaD
Flurbiprofen—Decreased appetite—Capecitabine—colon cancer	0.000117	0.000857	CcSEcCtD
Flurbiprofen—Constipation—Capecitabine—colon cancer	0.000115	0.000843	CcSEcCtD
Flurbiprofen—Pain—Capecitabine—colon cancer	0.000115	0.000843	CcSEcCtD
Flurbiprofen—Nausea—Fluorouracil—colon cancer	0.000114	0.000838	CcSEcCtD
Flurbiprofen—Nitrazepam—ABCB1—colon cancer	0.000114	0.0262	CrCbGaD
Flurbiprofen—Ill-defined disorder—Methotrexate—colon cancer	0.000114	0.000834	CcSEcCtD
Flurbiprofen—Anaemia—Methotrexate—colon cancer	0.000113	0.000831	CcSEcCtD
Flurbiprofen—Feeling abnormal—Capecitabine—colon cancer	0.000111	0.000813	CcSEcCtD
Flurbiprofen—Malaise—Methotrexate—colon cancer	0.00011	0.000811	CcSEcCtD
Flurbiprofen—Vertigo—Methotrexate—colon cancer	0.00011	0.000808	CcSEcCtD
Flurbiprofen—UGT2B7—Metabolism—CA7—colon cancer	0.00011	0.00436	CbGpPWpGaD
Flurbiprofen—Gastrointestinal pain—Capecitabine—colon cancer	0.00011	0.000806	CcSEcCtD
Flurbiprofen—Leukopenia—Methotrexate—colon cancer	0.00011	0.000805	CcSEcCtD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000109	0.00433	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000109	0.00433	CbGpPWpGaD
Flurbiprofen—Cough—Methotrexate—colon cancer	0.000107	0.000785	CcSEcCtD
Flurbiprofen—Urticaria—Capecitabine—colon cancer	0.000107	0.000783	CcSEcCtD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000106	0.00421	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000106	0.00421	CbGpPWpGaD
Flurbiprofen—Body temperature increased—Capecitabine—colon cancer	0.000106	0.000779	CcSEcCtD
Flurbiprofen—Abdominal pain—Capecitabine—colon cancer	0.000106	0.000779	CcSEcCtD
Flurbiprofen—Convulsion—Methotrexate—colon cancer	0.000106	0.000779	CcSEcCtD
Flurbiprofen—Myalgia—Methotrexate—colon cancer	0.000104	0.000766	CcSEcCtD
Flurbiprofen—Discomfort—Methotrexate—colon cancer	0.000103	0.000757	CcSEcCtD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	0.000101	0.00401	CbGpPWpGaD
Flurbiprofen—Confusional state—Methotrexate—colon cancer	0.000101	0.00074	CcSEcCtD
Flurbiprofen—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	0.0001	0.00397	CbGpPWpGaD
Flurbiprofen—Anaphylactic shock—Methotrexate—colon cancer	0.0001	0.000734	CcSEcCtD
Flurbiprofen—Infection—Methotrexate—colon cancer	9.93e-05	0.000729	CcSEcCtD
Flurbiprofen—Hypersensitivity—Capecitabine—colon cancer	9.9e-05	0.000726	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Methotrexate—colon cancer	9.79e-05	0.000719	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Methotrexate—colon cancer	9.67e-05	0.00071	CcSEcCtD
Flurbiprofen—Asthenia—Capecitabine—colon cancer	9.64e-05	0.000707	CcSEcCtD
Flurbiprofen—Anorexia—Methotrexate—colon cancer	9.53e-05	0.0007	CcSEcCtD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	9.5e-05	0.00377	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	9.5e-05	0.00377	CbGpPWpGaD
Flurbiprofen—Pruritus—Capecitabine—colon cancer	9.5e-05	0.000698	CcSEcCtD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	9.47e-05	0.00376	CbGpPWpGaD
Flurbiprofen—Hypotension—Methotrexate—colon cancer	9.34e-05	0.000686	CcSEcCtD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	9.32e-05	0.00369	CbGpPWpGaD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	9.32e-05	0.00369	CbGpPWpGaD
Flurbiprofen—Diarrhoea—Capecitabine—colon cancer	9.19e-05	0.000675	CcSEcCtD
Flurbiprofen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	9.12e-05	0.00361	CbGpPWpGaD
Flurbiprofen—Musculoskeletal discomfort—Methotrexate—colon cancer	9.11e-05	0.000669	CcSEcCtD
Flurbiprofen—Insomnia—Methotrexate—colon cancer	9.04e-05	0.000664	CcSEcCtD
Flurbiprofen—Paraesthesia—Methotrexate—colon cancer	8.98e-05	0.000659	CcSEcCtD
Flurbiprofen—UGT1A1—Metabolism—CA7—colon cancer	8.93e-05	0.00354	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CA7—colon cancer	8.93e-05	0.00354	CbGpPWpGaD
Flurbiprofen—Dyspnoea—Methotrexate—colon cancer	8.91e-05	0.000654	CcSEcCtD
Flurbiprofen—Somnolence—Methotrexate—colon cancer	8.89e-05	0.000653	CcSEcCtD
Flurbiprofen—Dizziness—Capecitabine—colon cancer	8.88e-05	0.000652	CcSEcCtD
Flurbiprofen—Dyspepsia—Methotrexate—colon cancer	8.8e-05	0.000646	CcSEcCtD
Flurbiprofen—Decreased appetite—Methotrexate—colon cancer	8.69e-05	0.000638	CcSEcCtD
Flurbiprofen—Pain—Methotrexate—colon cancer	8.55e-05	0.000628	CcSEcCtD
Flurbiprofen—Vomiting—Capecitabine—colon cancer	8.54e-05	0.000627	CcSEcCtD
Flurbiprofen—Rash—Capecitabine—colon cancer	8.47e-05	0.000622	CcSEcCtD
Flurbiprofen—Dermatitis—Capecitabine—colon cancer	8.46e-05	0.000621	CcSEcCtD
Flurbiprofen—Headache—Capecitabine—colon cancer	8.41e-05	0.000618	CcSEcCtD
Flurbiprofen—UGT1A9—PPARA activates gene expression—PPARG—colon cancer	8.32e-05	0.0033	CbGpPWpGaD
Flurbiprofen—Feeling abnormal—Methotrexate—colon cancer	8.24e-05	0.000605	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Methotrexate—colon cancer	8.18e-05	0.0006	CcSEcCtD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	8.14e-05	0.00323	CbGpPWpGaD
Flurbiprofen—Diazepam—ABCB1—colon cancer	8.06e-05	0.0185	CrCbGaD
Flurbiprofen—Nausea—Capecitabine—colon cancer	7.98e-05	0.000586	CcSEcCtD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	7.97e-05	0.00316	CbGpPWpGaD
Flurbiprofen—Urticaria—Methotrexate—colon cancer	7.94e-05	0.000583	CcSEcCtD
Flurbiprofen—Abdominal pain—Methotrexate—colon cancer	7.9e-05	0.00058	CcSEcCtD
Flurbiprofen—Body temperature increased—Methotrexate—colon cancer	7.9e-05	0.00058	CcSEcCtD
Flurbiprofen—UGT1A3—Metabolism—CHST5—colon cancer	7.83e-05	0.0031	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ODC1—colon cancer	7.83e-05	0.0031	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet degranulation—VEGFA—colon cancer	7.69e-05	0.00305	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	7.43e-05	0.00295	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	7.39e-05	0.00293	CbGpPWpGaD
Flurbiprofen—Hypersensitivity—Methotrexate—colon cancer	7.37e-05	0.000541	CcSEcCtD
Flurbiprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	7.33e-05	0.00291	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CA7—colon cancer	7.28e-05	0.00289	CbGpPWpGaD
Flurbiprofen—Asthenia—Methotrexate—colon cancer	7.17e-05	0.000527	CcSEcCtD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—EP300—colon cancer	7.07e-05	0.0028	CbGpPWpGaD
Flurbiprofen—Pruritus—Methotrexate—colon cancer	7.07e-05	0.000519	CcSEcCtD
Flurbiprofen—ABCC4—Platelet degranulation—TGFB1—colon cancer	7.06e-05	0.0028	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—SRC—colon cancer	6.88e-05	0.00273	CbGpPWpGaD
Flurbiprofen—Diarrhoea—Methotrexate—colon cancer	6.84e-05	0.000502	CcSEcCtD
Flurbiprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	6.73e-05	0.00267	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	6.7e-05	0.00266	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CHST5—colon cancer	6.66e-05	0.00264	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ODC1—colon cancer	6.66e-05	0.00264	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	6.62e-05	0.00262	CbGpPWpGaD
Flurbiprofen—Dizziness—Methotrexate—colon cancer	6.61e-05	0.000485	CcSEcCtD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	6.38e-05	0.00253	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	6.37e-05	0.00253	CbGpPWpGaD
Flurbiprofen—Vomiting—Methotrexate—colon cancer	6.36e-05	0.000467	CcSEcCtD
Flurbiprofen—Rash—Methotrexate—colon cancer	6.3e-05	0.000463	CcSEcCtD
Flurbiprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	6.3e-05	0.0025	CbGpPWpGaD
Flurbiprofen—Dermatitis—Methotrexate—colon cancer	6.3e-05	0.000462	CcSEcCtD
Flurbiprofen—Headache—Methotrexate—colon cancer	6.26e-05	0.00046	CcSEcCtD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—MYC—colon cancer	6.16e-05	0.00244	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	6.03e-05	0.00239	CbGpPWpGaD
Flurbiprofen—Nausea—Methotrexate—colon cancer	5.94e-05	0.000436	CcSEcCtD
Flurbiprofen—PTGS2—Metabolism—CA7—colon cancer	5.78e-05	0.00229	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	5.7e-05	0.00226	CbGpPWpGaD
Flurbiprofen—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	5.65e-05	0.00224	CbGpPWpGaD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	5.61e-05	0.00222	CbGpPWpGaD
Flurbiprofen—UGT1A3—NRF2 pathway—TGFB1—colon cancer	5.46e-05	0.00216	CbGpPWpGaD
Flurbiprofen—UGT1A9—PPARA activates gene expression—EP300—colon cancer	5.44e-05	0.00216	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CHST5—colon cancer	5.41e-05	0.00215	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ODC1—colon cancer	5.41e-05	0.00215	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ODC1—colon cancer	5.41e-05	0.00215	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CHST5—colon cancer	5.41e-05	0.00215	CbGpPWpGaD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	5.33e-05	0.00211	CbGpPWpGaD
Flurbiprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	5.27e-05	0.00209	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	4.98e-05	0.00197	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	4.89e-05	0.00194	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	4.84e-05	0.00192	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—CCND1—colon cancer	4.75e-05	0.00188	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	4.71e-05	0.00187	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CA7—colon cancer	4.68e-05	0.00185	CbGpPWpGaD
Flurbiprofen—UGT2B7—NRF2 pathway—TGFB1—colon cancer	4.64e-05	0.00184	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—CDKN1A—colon cancer	4.59e-05	0.00182	CbGpPWpGaD
Flurbiprofen—ABCC4—Ectoderm Differentiation—MYC—colon cancer	4.58e-05	0.00181	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CHST5—colon cancer	4.41e-05	0.00175	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ODC1—colon cancer	4.41e-05	0.00175	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—EP300—colon cancer	4.37e-05	0.00173	CbGpPWpGaD
Flurbiprofen—ABCC4—NRF2 pathway—TGFB1—colon cancer	4.36e-05	0.00173	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—LGR5—colon cancer	4.18e-05	0.00166	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CHST5—colon cancer	4.18e-05	0.00166	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	4.1e-05	0.00162	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	4.09e-05	0.00162	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—ABCB1—colon cancer	3.86e-05	0.00153	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CA7—colon cancer	3.83e-05	0.00152	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—MYC—colon cancer	3.81e-05	0.00151	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—TYMS—colon cancer	3.79e-05	0.0015	CbGpPWpGaD
Flurbiprofen—UGT1A9—NRF2 pathway—TGFB1—colon cancer	3.77e-05	0.0015	CbGpPWpGaD
Flurbiprofen—UGT1A1—NRF2 pathway—TGFB1—colon cancer	3.77e-05	0.0015	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—CASP3—colon cancer	3.72e-05	0.00147	CbGpPWpGaD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	3.67e-05	0.00145	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—CCND1—colon cancer	3.62e-05	0.00143	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	3.59e-05	0.00142	CbGpPWpGaD
Flurbiprofen—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	3.58e-05	0.00142	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	3.53e-05	0.0014	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	3.52e-05	0.00139	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	3.5e-05	0.00139	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ODC1—colon cancer	3.5e-05	0.00139	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CHST5—colon cancer	3.5e-05	0.00139	CbGpPWpGaD
Flurbiprofen—ALB—Platelet degranulation—VEGFA—colon cancer	3.48e-05	0.00138	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	3.41e-05	0.00135	CbGpPWpGaD
Flurbiprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	3.32e-05	0.00131	CbGpPWpGaD
Flurbiprofen—ALB—Platelet degranulation—TGFB1—colon cancer	3.2e-05	0.00127	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	3.13e-05	0.00124	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	3.07e-05	0.00122	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—TP53—colon cancer	3.07e-05	0.00122	CbGpPWpGaD
Flurbiprofen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	3.04e-05	0.00121	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AXIN2—colon cancer	3e-05	0.00119	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	2.99e-05	0.00119	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—MYC—colon cancer	2.9e-05	0.00115	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	2.89e-05	0.00115	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—EGFR—colon cancer	2.84e-05	0.00112	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ODC1—colon cancer	2.83e-05	0.00112	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CHST5—colon cancer	2.83e-05	0.00112	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PPARG—colon cancer	2.69e-05	0.00107	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	2.67e-05	0.00106	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.53e-05	0.001	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.46e-05	0.000975	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.44e-05	0.000966	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TP53—colon cancer	2.38e-05	0.000945	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.38e-05	0.000944	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CHST5—colon cancer	2.32e-05	0.000919	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ODC1—colon cancer	2.32e-05	0.000919	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.26e-05	0.000898	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.23e-05	0.000886	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.2e-05	0.000873	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	2.18e-05	0.000863	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.15e-05	0.00085	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PTGS2—colon cancer	2.11e-05	0.000838	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ABCB1—colon cancer	2.07e-05	0.00082	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—TYMS—colon cancer	2.03e-05	0.000806	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.97e-05	0.000782	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.97e-05	0.000781	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.93e-05	0.000765	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—EP300—colon cancer	1.86e-05	0.000736	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.82e-05	0.000723	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.82e-05	0.000722	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—SRC—colon cancer	1.81e-05	0.000716	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ABCB1—colon cancer	1.76e-05	0.000698	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—VEGFA—colon cancer	1.76e-05	0.000697	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—EP300—colon cancer	1.76e-05	0.000697	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.76e-05	0.000697	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—NRAS—colon cancer	1.74e-05	0.000689	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—TYMS—colon cancer	1.73e-05	0.000685	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.68e-05	0.000664	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.62e-05	0.000643	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TGFB1—colon cancer	1.61e-05	0.00064	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	1.6e-05	0.000634	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	1.59e-05	0.000629	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.54e-05	0.000612	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—KRAS—colon cancer	1.5e-05	0.000593	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.46e-05	0.000579	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.45e-05	0.000573	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PPARG—colon cancer	1.44e-05	0.000571	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.43e-05	0.000568	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ABCB1—colon cancer	1.43e-05	0.000567	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ABCB1—colon cancer	1.43e-05	0.000567	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.42e-05	0.000562	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—TYMS—colon cancer	1.4e-05	0.000557	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—TYMS—colon cancer	1.4e-05	0.000557	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—PIK3CA—colon cancer	1.37e-05	0.000545	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.37e-05	0.000543	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TP53—colon cancer	1.33e-05	0.000527	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PIK3CA—colon cancer	1.3e-05	0.000516	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—HRAS—colon cancer	1.27e-05	0.000504	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARG—colon cancer	1.22e-05	0.000485	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.21e-05	0.000478	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.19e-05	0.000472	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.17e-05	0.000464	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ABCB1—colon cancer	1.17e-05	0.000462	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—TYMS—colon cancer	1.14e-05	0.000454	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTGS2—colon cancer	1.13e-05	0.000449	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—AKT1—colon cancer	1.12e-05	0.000445	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.08e-05	0.000429	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AKT1—colon cancer	1.06e-05	0.000421	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARG—colon cancer	9.95e-06	0.000394	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARG—colon cancer	9.95e-06	0.000394	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	9.85e-06	0.000391	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTGS2—colon cancer	9.63e-06	0.000382	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.57e-06	0.000379	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.46e-06	0.000375	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—EP300—colon cancer	9.42e-06	0.000373	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ABCB1—colon cancer	9.25e-06	0.000367	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.2e-06	0.000365	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—TYMS—colon cancer	9.09e-06	0.00036	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.81e-06	0.000349	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGFR3—colon cancer	8.67e-06	0.000344	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EP300—colon cancer	8.4e-06	0.000333	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—SRC—colon cancer	8.17e-06	0.000324	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARG—colon cancer	8.11e-06	0.000321	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—EP300—colon cancer	8.01e-06	0.000318	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APC—colon cancer	7.96e-06	0.000316	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VEGFA—colon cancer	7.96e-06	0.000316	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NRAS—colon cancer	7.86e-06	0.000312	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS2—colon cancer	7.83e-06	0.00031	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS2—colon cancer	7.83e-06	0.00031	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.65e-06	0.000303	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.53e-06	0.000299	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—BRAF—colon cancer	7.49e-06	0.000297	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ABCB1—colon cancer	7.49e-06	0.000297	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—TYMS—colon cancer	7.35e-06	0.000291	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TGFB1—colon cancer	7.31e-06	0.00029	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7e-06	0.000277	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CA—colon cancer	6.97e-06	0.000276	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—KRAS—colon cancer	6.77e-06	0.000268	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—EP300—colon cancer	6.51e-06	0.000258	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—EP300—colon cancer	6.51e-06	0.000258	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARG—colon cancer	6.44e-06	0.000255	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTGS2—colon cancer	6.38e-06	0.000253	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.26e-06	0.000248	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CA—colon cancer	6.22e-06	0.000246	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCB1—colon cancer	6.13e-06	0.000243	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TYMS—colon cancer	6.02e-06	0.000239	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—colon cancer	6.01e-06	0.000238	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CA—colon cancer	5.92e-06	0.000235	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—HRAS—colon cancer	5.75e-06	0.000228	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKT1—colon cancer	5.69e-06	0.000226	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.66e-06	0.000224	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CTNNB1—colon cancer	5.41e-06	0.000214	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—EP300—colon cancer	5.31e-06	0.00021	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1A—colon cancer	5.29e-06	0.00021	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARG—colon cancer	5.21e-06	0.000206	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT1—colon cancer	5.08e-06	0.000201	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EP300—colon cancer	5.03e-06	0.000199	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—SRC—colon cancer	4.89e-06	0.000194	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKT1—colon cancer	4.84e-06	0.000192	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CA—colon cancer	4.81e-06	0.000191	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CA—colon cancer	4.81e-06	0.000191	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NRAS—colon cancer	4.7e-06	0.000187	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.63e-06	0.000184	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MYC—colon cancer	4.38e-06	0.000174	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TGFB1—colon cancer	4.37e-06	0.000173	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EGFR—colon cancer	4.29e-06	0.00017	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARG—colon cancer	4.26e-06	0.000169	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—EP300—colon cancer	4.21e-06	0.000167	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS2—colon cancer	4.1e-06	0.000162	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KRAS—colon cancer	4.05e-06	0.000161	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKT1—colon cancer	3.93e-06	0.000156	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKT1—colon cancer	3.93e-06	0.000156	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CA—colon cancer	3.92e-06	0.000156	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CA—colon cancer	3.72e-06	0.000147	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HRAS—colon cancer	3.44e-06	0.000136	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—EP300—colon cancer	3.41e-06	0.000135	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS2—colon cancer	3.35e-06	0.000133	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKT1—colon cancer	3.21e-06	0.000127	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CA—colon cancer	3.12e-06	0.000124	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT1—colon cancer	3.04e-06	0.00012	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—EP300—colon cancer	2.79e-06	0.000111	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKT1—colon cancer	2.55e-06	0.000101	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CA—colon cancer	2.52e-06	9.99e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CA—colon cancer	2.06e-06	8.18e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKT1—colon cancer	2.06e-06	8.16e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKT1—colon cancer	1.69e-06	6.68e-05	CbGpPWpGaD
